Search Results for "Updated results of BCMA"

Updated results of BCMA/CD19 dual-targeting fast CAR-T GC012F dual-targeting CAR-T in RRMM

Updated Study Results of BCMA/CD19 Dual-Targeting CAR-T GC012F for RRMM Patients

Updated Phase I results from SGNBCMA-001 study of SEA-BCMA in patients with R/R multiple myeloma

Updated phase 1 results of teclistamab, a BCMA × CD3 bispecific antibody, in RRMM

180 Updated Phase 1 Results of Teclistamab, a BCMA x CD3 Bispecific Antibody

Results of a Phase I trial of HBI0101, an anti-BCMA CAR T-cell therapy, for R/R multiple myeloma

Updated Results from CARTITUDE-1: Phase 1b/2Study of Cilta-Cel in Pts With RR Multiple Myeloma

Updated Results (2 years post-LPI) in Phase 1b/2 (CARTITUDE-1) Study of Cilta-Cel in RRMM patients

Updated results from MajesTEC-1

Teclistamab, a BCMA × Cd3 Bispecific Antibody, in Pts with RRMM: Updated Phase 1 Results

Updated Efficacy/Safety Results of MajesTEC-1 (Teclistamab) at ASCO 2022

Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy